Ostronic Francis Patrick 4
4 · Cyclo Therapeutics, Inc. · Filed Nov 30, 2023
Insider Transaction Report
Form 4
Ostronic Francis Patrick
Director
Transactions
- Award
Common Stock
2023-11-28+10,262→ 329,325 total
Footnotes (1)
- [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee directorcompensation policy. Grant reflects director compensation for the third quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.34per share of common stock on November 28, 2023.